Citadel Advisors »

Alnylam Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $18M 726k 24.37
2012-12-31 $13M 701k 18.25
2012-09-30 $9.6M 512k 18.79
2012-03-31 $106k 9.6k 11.04
2011-12-31 $413k 51k 8.16
2011-09-30 $395k 60k 6.56
2011-06-30 $576k 62k 9.37
2011-03-31 $496k 52k 9.57
2010-12-31 $33k 3.4k 9.80